Pinz Capital Management, LP Karuna Therapeutics, Inc. Transaction History

Pinz Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$107.45 - $135.95 $3.1 Million - $3.92 Million	-28,805 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$95.46 - $133.08 $2.75 Million - $3.83 Million	28,805 New	28,805 $3.46 Million
Q2 2020 Aug 14, 2020	SELL	$62.14 - $117.21 $35,606 - $67,161	-573 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$60.41 - $115.92 $911,405 - $1.75 Million	-15,087 Reduced 96.34%	573 $41,000
Q4 2019 Feb 12, 2020	BUY	$11.44 - $123.99 $179,150 - $1.94 Million	15,660 New	15,660 $1.18 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Pinz Capital Management, LP with notifications on news.